Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study Academic Article uri icon

Overview

MeSH Major

  • Atenolol
  • Electrocardiography
  • Hypertrophy, Left Ventricular
  • Losartan

abstract

  • After adjusting for baseline and in-treatment blood pressure and baseline severity of ECG LVH, losartan-based antihypertensive therapy resulted in greater regression of ECG LVH by Cornell voltage-duration product and Sokolow-Lyon voltage criteria than did atenolol-based therapy. These findings support the value of angiotensin receptor blockade with losartan for reversing ECG LVH.

publication date

  • August 12, 2003

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1161/01.CIR.0000083724.28630.C3

PubMed ID

  • 12885747

Additional Document Info

start page

  • 684

end page

  • 90

volume

  • 108

number

  • 6